Characteristics of the study group
Ninety-seven (n=97) participants constitute the study sample. As shown in Table 1, the majority of participants were older than 35 years of age (54.7%), with a median age of 37 years old (p25-p75, 31-44), and 54,6% lived in Ciudad Autónoma de Buenos Aires. Four participants reported living in informal housing, like shantytowns. Regarding formal education level, 76.3% completed more than high school level. More than half (54.2%) had a formal job and 40.2% had social security. Most of the participants (95.9%) were under HIV treatment. While all participants were diagnosed with HIV and started medical care at Nexo AC, 25.8% continue under care in other medical centers.
Social and sexual relationships
Regarding social and sexual relationships during confinement, MSM reported being in contact (including remote and face-to-face contact) with a median of 10 individuals for 12 days of the previous two weeks. This data is in line with the fact that 68% of MSM received some kind of support (emotional or economical) almost once a week. However, participants had close contact with a median of 2 persons and for a median of 4 days during the previous two weeks. When specifically asked about sexual partners, 84.5% of MSM reported having had 1 or no partners during the previous 2 weeks. In relation with perception of impact on their sexual activity, 43% of participants felt that confinement “much or extremely” impacted their sexual activity. In fact, 41.3% of them stated that they had sex with their main partner less frequently and 57.1% that they had sex less frequently. No cases of intimate partner violence were reported in the sample (Table 2).
HIV and COVID-19 related issues
Among those under HIV treatment, 87.1% reported no changes on their use of HIV medication, while 8.6% MSM reported missing their medication less frequently and 4.3% participants, more frequently during confinement. On the other hand, 18.3% of participants reported having had problems with the access to HIV medication, 12.4% with finding STIs services and 9.3% with finding healthcare providers (Table 1S).
Among COVID-19 outcomes, 62.9% believed there was some likelihood of becoming ill with coronavirus, 15.4% believed there was some likelihood of having had sex with someone with coronavirus, 6.2% experienced symptoms, 5.2% were tested, and 1% was diagnosed with SARS-CoV-2. In relation to information about COVID-19, 7.2% reported being confused about the nature of the disease, how to prevent it and/or the need for distancing measures. When participants were asked about a list of preventive measures against COVID-19, a high percentage of participants agreed with most of the popular recommendations like “practicing social distancing”, “wearing a face mask”, “washing hands”, and “using hand sanitizer” (Table 2S).
Substance use
Half of the group (50.5%) did not change their drinking behavior, 3.1% had drunk more, 18.6% had drunk less, and 27.8% never drunk. In relation with smoke habits, almost 70% did not smoke, and, according to previously reported classification, 20.3% are light (<1-5 cigarettes per day), 3.1% moderate (6-10 cigarettes per day), and 7.2% severe smokers (>10 cigarettes per day) [12]. Regarding other drugs consumed in the past 2 weeks, marijuana use was reported by 16.5%, sedatives and sleeping pills by 10.3%, and cocaine by 2.1% of the MSM (Table 3S).
Mental health
In order to study the impact of the COVID-19 pandemic and confinement on mental health, we asked MSM about fears and concerns. Most of the MSM (74.2%) reported having been somewhat or very concerned about coronavirus in the previous 2 weeks. A total of 55.7% felt nervous, anxious or on edge, 46.4% felt depressed, 43.3% felt lonely at least 1 day during the previous 7 days. A total of 23.7% felt hopeful about the future most of the days (5-7 days per week). Additionally, 23.7% had physical reactions when thinking about the pandemic. Regarding the feeling of having any loss or problems during the pandemic, 55.3%, 34.4%, 21.9%, 18.7%, and 8.2% reported loss or fear of losing their source of income, health insurance, enough food, enough medication, and a place to stay, respectively. More detailed information is available on Table 3.
Using the variables related to nervousness/anxiety, depression, and loneliness, a psychological distress score was calculated with a mean value of 5 (p25-p75, 3-7). As shown on table 4, a higher score was significantly associated with a greater impact on sexual activity (p<0.001), having had negative physical reactions (sweating, trouble breathing, nausea, or heart palpitations) when thinking of COVID-19 (p=0.008), not being at Nexo under care (p=0.037), loss or fear of losing their health insurance (p=0.003), or a place to stay (p=0.002), due to the pandemic.
Qualitative Results
In-depth interviews of six HIV-positive patients and three system representatives (Nexo coordinator, Nexo physician and health government representatives) reveal that individuals with HIV had an increased risk perception of COVID-19 due to their HIV status, despite little research confirming that HIV indeed increases COVID-19 risk. In this line we found dissimilar results: we observed patients who interrupted their HIV treatment because they did not feel safe going to the pharmacy, and also patients who increased treatment adherence and patients who resumed treatment during the pandemic because they felt more vulnerable to COVID-19. All participants expressed some degree of concern, fear and discomfort about the quarantine situation and the spread of COVID-19. Participants mentioned that changes in mood were related to the situation of confinement, the inability of meeting in person, and in some cases, the loss of work.
Participants who needed to attend health services during the quarantine did not report problems receiving care, solving problems in person or in many cases, virtually. Information from all the interviews reveals that HIV treatment interruptions were few and if an interruption occurred it was for less than one month. The main reason cited for treatment interruption was that patients were not able to go to the hospital pharmacy because of mobility restrictions, however subsequent authorizations implemented helped to remedy this issue. Other difficulties cited by patients with social security and prepaid insurance plans were that medication deliveries were not being sent in the appropriate amount of time.
Nexo NGO was adapting rapidly to the COVID-19 situation by providing multiple options for patients to receive prescriptions and medical care. The use of virtual means of communication through email and WhatsApp had been implemented in the organization before COVID-19 so the negative impact of transitioning from face-to-face encounters was diminished. In preparation for appointments, the coordinator mentions the development of a system to better prepare for virtual appointments with HIV care providers. This includes asking for related health information for the reason of their visit such as pictures of injuries, full list of symptoms, and other supporting information. This information is then combined and sent to the attending provider before their appointment.
The Health Systems representative recognized the rapid capacity of HIV care to meet the demands of HIV patients during COVID-19. The representative emphasized that this was the result of coordinated work between different levels of government and in coordination with civil society organizations, which deployed a group of volunteers to deliver medications to patients who could not receive them otherwise. Additionally, the provider stated that all emergency situations were dealt with without difficulties and that they were able to effectively solve them by phone or video call. In agreement with the other participants, they mentioned the changes in provision of necessary medications with a photo of a prescription, later without a prescription, and then patients were given medication for 2 or 3 months to reduce their need to mobilize.
In addition, given the precariousness of the labor market, there has been an increase in the number of patients returning to government funded healthcare because patients no longer have social security nor prepaid insurance due to the impossibility of sustaining payments. In regards to the future, they emphasized the need to organize the demand for viral load studies after COVID-19 as they have been suspended. This will be a topic in which the situation of each patient, their treatments, the time without studies, among other variables, will have to be considered.